Aspergillus IgM

Aspergillus IgM is an IgM antibody produced by the immune system in response to Aspergillus species. Its detection in blood serology suggests recent or acute exposure or infection, but results can be variable. It can indicate early infection when interpreted alongside clinical signs, imaging and other tests (IgG, culture, antigen or PCR). Clinical context is essential because sensitivity and specificity are limited.

A positive Aspergillus IgG indicates an immune response to Aspergillus, suggesting prior exposure, chronic infection (for example chronic pulmonary aspergillosis), or long-term airway colonization rather than acute invasive disease. It supports the diagnosis when coupled with compatible symptoms and chest imaging. Results can be false positive or cross-reactive, so clinicians use IgG alongside clinical assessment, imaging, and mycology to guide management.

A positive IgM and IgG result means your body has mounted both an early and a later antibody response. IgM suggests recent or active infection; IgG indicates past exposure, developing or longer-term antibodies and possible immunity. Both positive together often indicate a recent infection now progressing toward recovery. Results must be interpreted with symptoms, vaccination status, and confirmatory tests (e.g., PCR); consult your healthcare provider.

Aspergillus is a common mold found in soil, decaying vegetation, and indoor dust. Most species are harmless to healthy people, but some produce toxins (e.g., aflatoxins) or cause allergic reactions and lung infections (aspergillosis), especially in people with weakened immunity or chronic lung disease. Risk increases with high spore exposure; good ventilation, controlling dampness, and avoiding moldy environments reduce risk.

Some Aspergillus infections are curable or controllable, but it depends on the type and host immunity. Allergic forms are managed (not cured) with steroids and antifungals; chronic pulmonary disease often needs long-term antifungals and may not be eradicated. Invasive aspergillosis can be life‑threatening but is treatable with systemic antifungal therapy and sometimes surgery—early treatment and immune recovery improve cure chances.

No. Aspergillus is a fungus that causes aspergillosis, not tuberculosis. TB is caused by the bacterium Mycobacterium tuberculosis. Both can affect the lungs and share symptoms like cough and weight loss, but they need different tests and treatments — antifungals for aspergillosis and specific antitubercular antibiotics for TB. Accurate clinical diagnosis is essential.